Insulin resistance and steatosis in hepatitis C virus infection.
about
Alcoholic liver disease and hepatitis C virus infectionPost-load insulin resistance is an independent predictor of hepatic fibrosis in virus C chronic hepatitis and in non-alcoholic fatty liver diseaseTreatment responses in Asians and Caucasians with chronic hepatitis C infectionTopological and evolutional relationships between HCV core protein and hepatic lipid vesicles: studies in vitro and in conditionally transgenic mice.Effect of Breathwalk on body composition, metabolic and mood state in chronic hepatitis C patients with insulin resistance syndrome.Chemokine antagonism in chronic hepatitis C virus infectionMetabolic syndrome in patients with chronic hepatitis C virus genotype 1 infection who do not have obesity or type 2 diabetes.Effect of soy protein supplementation in patients with chronic hepatitis C: a randomized clinical trial.A growing burden: the pathogenesis, investigation and management of non-alcoholic fatty liver disease.Histological assessment of non-alcoholic fatty liver disease.Liver biopsy assessment in chronic viral hepatitis: a personal, practical approach.Chronic hepatitis C virus infection: genotyping and its clinical role.Metabolic alterations and chronic hepatitis C: treatment strategies.Tailor-made therapy for viral hepatitis: recent advances.Hepatitis C core protein impairs insulin downstream signalling and regulatory role of IGFBP-1 expression.n-3 polyunsaturated fatty acid supplementation reduces insulin resistance in hepatitis C virus infected patients: a randomised controlled trial.The impact of host metabolic factors on treatment outcome in chronic hepatitis C.Branched-chain amino acids improve insulin resistance in patients with hepatitis C virus-related liver disease: report of two cases.Correlation between insulin resistance and outcome of pegylated interferon and ribavirin therapy, hepatic steatosis, hepatic fibrosis in chronic hepatitis C-1b and high viral load.Evidence of oxidative stress as a cofactor in the development of insulin resistance in patients with chronic hepatitis C.Altered expression of glucagon-like peptide-1 and dipeptidyl peptidase IV in patients with HCV-related glucose intolerance.
P2860
Q26773274-71B5E45A-B7A7-45DD-95B1-65F32927FAA8Q27481042-1EE9CE7B-2808-49D1-8997-45E57F701863Q27489011-2060AC69-C3FA-40D1-837A-84EF9463C34BQ34098656-02F596BD-BA7A-48AB-83A0-CFE21C19CD29Q34225234-06FD03E9-19E8-4620-9829-FE18220DDE6BQ34429056-A6F10908-B32F-4AAF-8461-5251A3D6976CQ35813414-0873875A-6B16-487F-BF12-A2BC8C475157Q35958241-00C3A739-EFE8-46D4-B73E-E8307E0D3D83Q36172470-E408FAC0-1F96-4551-AE16-EF5AF30C62D0Q36634377-9F2962A0-FBDB-4735-AE63-A79073E337D1Q36814301-F7DCF27C-02CF-467B-B7B9-16A2833C97F5Q36895749-B7C5FEC3-C5A4-4EB9-A289-6982B889C05EQ37924816-E51D0546-7A16-4FE0-9FE7-55717850C164Q37966703-3794101A-A552-4F75-A5BF-A7D6D78C3A9EQ39424609-623F5633-1020-4E1F-BE28-D77AA359814FQ40689561-E25D4BD8-7C40-49B9-B79A-95E5A4B8BF7AQ42152130-C99B5384-A373-4FF3-9B30-D1B88F89D805Q43041205-04137C34-5053-4F7F-9DA3-3B930517396EQ43047753-CA7B889C-FAC2-4AF9-9129-06EACD150164Q46894724-8DAFD53F-E0CB-41B1-9EC7-0210789AFBDEQ46943450-884590C8-E486-4120-8FE7-947BC5E01FCE
P2860
Insulin resistance and steatosis in hepatitis C virus infection.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Insulin resistance and steatosis in hepatitis C virus infection.
@ast
Insulin resistance and steatosis in hepatitis C virus infection.
@en
type
label
Insulin resistance and steatosis in hepatitis C virus infection.
@ast
Insulin resistance and steatosis in hepatitis C virus infection.
@en
prefLabel
Insulin resistance and steatosis in hepatitis C virus infection.
@ast
Insulin resistance and steatosis in hepatitis C virus infection.
@en
P2860
P356
P1433
P1476
Insulin resistance and steatosis in hepatitis C virus infection
@en
P2093
J G McHutchison
P2860
P304
P356
10.1136/GUT.2004.059873
P407
P50
P577
2005-07-01T00:00:00Z